LIGAND PHARMACEUTICALS INC Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 493 | 0 | 39,806 | 39.3 K to 39.8 K (+1.25 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 493 | 0 | 39,806 | 39.3 K to 39.8 K (+1.25 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 493 | 0 | 54,056 | 53.6 K to 54.1 K (+0.92 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 493 | 0 | 54,056 | 53.6 K to 54.1 K (+0.92 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 493 | 0 | 1,406 | 913 to 1.4 K (+54.00 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 493 | 0 | 1,406 | 913 to 1.4 K (+54.00 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 493 | 0 | 59,118 | 58.6 K to 59.1 K (+0.84 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 493 | 0 | 59,118 | 58.6 K to 59.1 K (+0.84 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 493 | 0 | 21,449 | 21 K to 21.4 K (+2.35 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 493 | 0 | 21,449 | 21 K to 21.4 K (+2.35 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 493 | 0 | 31,142 | 30.6 K to 31.1 K (+1.61 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 493 | 0 | 31,142 | 30.6 K to 31.1 K (+1.61 %) |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 0.00 | 493 | 0 | 26,856 | 26.4 K to 26.9 K (+1.87 %) |
Jun 04 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | M | 12.53 | 4,000 | 50,120 | 3,335 | |
Jun 04 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Sell | S | 194.51 | 4,000 | 778,039 | 20,956 | 25 K to 21 K (-16.03 %) |
Jun 04 2018 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Buy | M | 12.53 | 4,000 | 50,120 | 24,956 | 21 K to 25 K (+19.09 %) |